Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase inhibitor 2 family member C (PPP1R2C) is an endogenous regulatory protein that inhibits the catalytic activity of protein phosphatase 1 (PP1), a major serine/threonine phosphatase involved in cell division, proliferation, and neuronal signaling. PPP1R2C is structurally and functionally similar to PPP1R2 (inhibitor-2), acting as part of a family of intrinsically disordered proteins that modulate PP1 function through direct binding and steric blocking of its active site. While its inhibition of PP1 is rapid and reversible, PPP1R2C is not implicated in direct disease causality or as a target for drugs. It is one of several regulatory subunits controlling PP1 activity, with broader biological implications for cell cycle regulation and neuronal processes.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase inhibitor 2 family member C (PPP1R2C).